Predictors and survival in patients with melanoma brain metastases. (Q48178499)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377924%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Predictors and survival in patients with melanoma brain metastases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377924%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377924%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Giovanni Paolino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377924%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Giovanni Paolino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377924%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Stefano Calvieri

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377924%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Rita Clerico

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377924%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Marina Ambrifi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377924%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Paola Corsetti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377924%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

2 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377924%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377924%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377924%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377924%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

466

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377924%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of brain metastases

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Incidence of intracranial tumours in the Lothian region of Scotland, 1989-90

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Melanoma brain metastases: is it time to reassess the bias?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Metastatic pattern of malignant melanoma. A study of 216 autopsy cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Chemoprevention for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Survival and prognostic factors in patients with brain metastases from malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Club de Cancérologie Cutanée

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Central nervous system involvement in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Determinants of survival in patients with brain metastases from cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Temozolomide in advanced malignant melanoma with small brain metastases: can we withhold cranial irradiation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Determinants of outcome in melanoma patients with cerebral metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Malignant melanoma brain metastases. Review of Roswell Park Memorial Institute experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Treatment of melanoma metastases in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Seizure prophylaxis and melanoma brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0466-2

Prognostic factors for survival in melanoma patients with brain metastases

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/23377924

12 December 2020

Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death

1 reference

https://pubmed.ncbi.nlm.nih.gov/23377924

12 December 2020

Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23377924

12 December 2020

Patterned distribution of metastases from malignant melanoma in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23377924

12 December 2020

Cerebral melanoma metastases: a critical review on diagnostic methods and therapeutic options.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23377924

12 December 2020

Selection of patients with melanoma brain metastases for aggressive treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/23377924

12 December 2020

10.1007/S12032-013-0466-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377924%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377924%20AND%20SRC:MED&resulttype=core&format=json